A clinical trial protocol for second line treatment of malignant brain tumors with BNCT at University of Tsukuba
- PMID: 21778066
- DOI: 10.1016/j.apradiso.2011.04.031
A clinical trial protocol for second line treatment of malignant brain tumors with BNCT at University of Tsukuba
Abstract
We have evaluated the efficacy and safety of boron neutron capture therapy (BNCT) for recurrent glioma and malignant brain tumor using a new protocol. One of the two patients enrolled in this trial is a man with recurrent glioblastoma and the other is a woman with anaplastic meningioma. Both are still alive and no severe adverse events have been observed. Our findings suggest that NCT will be safe as a palliative therapy for malignant brain tumors.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
